Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac Arrest

Uwe Zeymer1, Brunilda Alushi2, Marko Noc3

  • 1Klinikum Ludwigshafen, Ludwigshafen, Germany; Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany.

Insights

Cardiac arrest (CA) is common in patients with infarct-related cardiogenic shock (CS). While patients with CA were younger with fewer comorbidities, CA independently predicted 1-year mortality, underscoring the need for effective interventions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • Cardiac arrest (CA) is a frequent complication in patients experiencing infarct-related cardiogenic shock (CS).
  • Understanding the characteristics and outcomes of patients with CS, stratified by the presence of CA, is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To analyze the clinical characteristics and outcomes of patients with infarct-related CS, specifically comparing those with and without cardiac arrest.
  • To evaluate the impact of culprit lesion percutaneous coronary intervention (PCI) in patients with CS, stratified by CA, within the CULPRIT-SHOCK trial and registry.

Main Methods:

  • Analysis of 1,015 patients from the CULPRIT-SHOCK study, divided into groups with and without CA.
  • Assessment of 30-day composite outcomes (all-cause death or severe renal failure) and 1-year mortality.
  • Multivariate analysis to identify independent predictors of mortality.

Main Results:

  • Over 50% of patients with CS experienced CA; these patients were younger with fewer comorbidities.
  • No significant difference in 30-day composite outcomes or 1-year mortality between CA and non-CA groups.
  • Cardiac arrest (CA) was identified as an independent predictor of 1-year mortality (HR: 1.27).
  • Culprit lesion-only PCI demonstrated superiority over immediate multivessel PCI in both CA and non-CA patient groups.

Conclusions:

  • Cardiac arrest (CA) occurs in over half of patients with infarct-related CS and is an independent predictor of long-term mortality.
  • Despite younger age and fewer comorbidities, CA signifies a poorer prognosis.
  • Culprit lesion-only PCI is the recommended revascularization strategy for patients with CS, irrespective of CA status.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
52
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
26
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20